These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1979198

  • 1. [The inhibition of dopamine D1 and D2 receptors in human putamen by antipsychotic drugs].
    Kobayashi T, Shimizu H, Toru M.
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):331-4. PubMed ID: 1979198
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
    Chu J, Wilczynski W, Wilcox RE.
    Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
    [Abstract] [Full Text] [Related]

  • 6. Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brain.
    Andersen PH.
    Eur J Pharmacol; 1988 Jan 27; 146(1):113-20. PubMed ID: 2895008
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroleptics have identical potencies in human brain limbic and putamen regions.
    Seeman P, Ulpian C.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):145-8. PubMed ID: 6140171
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J, Briley M, Langer SZ.
    Eur J Pharmacol; 1983 Mar 18; 88(1):11-26. PubMed ID: 6133762
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autoradiography of dopamine D2 receptors using [3H]YM-09151-2.
    Cox RF, Waszczak BL.
    Eur J Pharmacol; 1991 Jun 18; 199(1):103-6. PubMed ID: 1680055
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
    Florijn WJ, Tarazi FI, Creese I.
    J Pharmacol Exp Ther; 1997 Feb 18; 280(2):561-9. PubMed ID: 9023264
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
    Obuchowicz E, Turchan J.
    Eur Neuropsychopharmacol; 1999 Jan 18; 9(1-2):51-9. PubMed ID: 10082228
    [Abstract] [Full Text] [Related]

  • 19. Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum.
    Terai M, Hidaka K, Nakamura Y.
    Eur J Pharmacol; 1989 Dec 07; 173(2-3):177-82. PubMed ID: 2576228
    [Abstract] [Full Text] [Related]

  • 20. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M, Battaini F, Spano PF, Trabucchi M.
    Acta Psychiatr Scand; 1981 Apr 07; 63(4):314-24. PubMed ID: 7315480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.